Butorphanol Tartrate Spray
Product Images NDC 60505-0813

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Butorphanol Tartrate (NDC 60505-0813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure2.jpg (Figure2)

FDA Label Image

Figure3.jpg (Figure3)

FDA Label Image

Figure4.jpg (Figure4)

FDA Label Image

Figure5.jpg (Figure5)

FDA Label Image

Figure6.jpg (Figure6)

FDA Label Image

Figure7.jpg (Figure7)

FDA Label Image

Btl-lbl-2.5ml.jpg (Btl Lbl 2.5ml)

This is a medication description for a nasal spray called Butorphanol Tartrate. The nasal spray comes in a 2.5mL bottle and is meant for nasal use only. Each milliliter of the spray contains 10mg of Butorphanol Tartrate. The manufacturer is Apotex Inc. based in Toronto, Ontario. The medication should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) as per USP Controlled Room Temperature guidelines. The NDC number for the medication is 60505-0813-1.*

FDA Label Image

Figure.jpg (Figure)

This appears to be a graph with two lines showing plasma concentration in nanograms per milliliter over time (in hours) for two different groups (one with IV treatment and one with NS treatment). However, the graph is not readable and needs to be properly formatted to extract meaningful information.*

FDA Label Image

Structure.jpg (Structure)

FDA Label Image

Symbol.jpg (Symbol)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.